CPIX
What one share of Cumberland Pharmaceuticals holds
Pharmaceutical Preparations
Cumberland Pharmaceuticals Inc. ("Cumberland," the "Company," or as used in the context of "we," "us" or "our"), is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceuticals.
Cumberland Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.98 |
|---|---|
| Profit | −$0.73 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.05 |
| Cash and investments | $0.26 |
| Book value | $1.16 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $2.03 | −$0.06 | $0.01 | $0.03 | — | $4.56 |
| 2017 | $2.59 | −$0.50 | $0.02 | −$0.05 | — | $3.99 |
| 2018 | $1.88 | −$0.45 | $0.03 | $0.17 | — | $3.61 |
| 2019 | $2.23 | −$0.23 | $0.02 | $0.18 | — | $3.35 |
| 2020 | $2.47 | −$0.22 | $0.01 | $0.35 | — | $3.14 |
| 2021 | $2.41 | −$0.24 | $0.01 | $0.42 | — | $2.90 |
| 2022 | $2.88 | −$0.38 | $0.01 | $0.57 | — | $2.52 |
| 2023 | $2.77 | −$0.44 | $0.02 | $0.41 | — | $2.10 |
| 2024 | $2.69 | −$0.46 | $0.00 | −$0.05 | — | $1.64 |
| 2025 | $3.00 | −$0.19 | $0.01 | $0.33 | — | $1.66 |